title: Preparation and characterization of microparticles of piroxicam by spray drying and spray chilling methods.
abstract: Piroxicam, an anti-inflammatory drug, exhibits poor water solubility and flow properties, poor dissolution and poor wetting. Consequently, the aim of this study was to improve the dissolution of piroxicam. Microparticles containing piroxicam were produced by spray drying, using isopropyl alcohol and water in the ratio of 40:60 v/v as solvent system, and spray chilling technology by melting the drug and chilling it with a pneumatic nozzle to enhance dissolution rate. The prepared formulations were evaluated for in vitro dissolution and solubility. The prepared drug particles were characterized by scanning electron microscopy (SEM), differential scanning calorimeter, X-ray diffraction and Fourier transform infrared spectroscopy. Dissolution profile of the spray dried microparticles was compared with spray-chilled microparticles, pure and recrystallized samples. Spray dried microparticles and spray chilled microparticles exhibited decreased crystallinity and improved micromeritic properties. The dissolution of the spray dried microparticle and spray chilled particles were improved compared with recrystallized and pure sample of piroxicam. Consequently, it was believed that spray drying of piroxicam is a useful tool to improve dissolution but not in case of spray chilling. This may be due to the degradation of drug or variations in the resonance structure or could be due to minor distortion of bond angles. Hence, this spray drying technique can be used for formulation of tablets of piroxicam by direct compression with directly compressible tablet excipients.
authors: Department of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysore-570015, India.
authors: M
authors: M
authors: Dixit
authors: A G
authors: AG
authors: Kini
authors: P K
authors: PK
authors: Kulkarni
references: Drug Discov Today. 2007 Dec;12(23-24):1068-75
references: 18061887
references: J Microencapsul. 1998 May-Jun;15(3):299-318
references: 9608394
references: Pak J Pharm Sci. 2010 Jul;23(3):284-90
references: 20566441
references: J Pharm Sci. 2009 Jul;98(7):2422-31
references: 18972575
references: Drug Dev Ind Pharm. 2002 Nov;28(10):1213-20
references: 12476867
references: Int J Pharm. 2004 Apr 1;273(1-2):171-82
references: 15010141
references: Int J Pharm. 2007 Oct 1;343(1-2):228-37
references: 17597315
references: Eur J Pharm Biopharm. 2005 Apr;59(3):565-73
references: 15760738
references: Int J Pharm. 2002 Jan 14;231(2):131-44
references: 11755266
references: J Pharm Sci. 2001 Oct;90(10):1620-7
references: 11745720
references: Drug Dev Ind Pharm. 2008 Oct;34(10):1013-21
references: 18686087
references: Int J Pharm. 2003 Apr 14;255(1-2):33-42
references: 12672599
references: Int J Pharm. 2004 Jan 28;269(2):443-50
references: 14706255
references: Int J Food Sci Nutr. 1999 May;50(3):213-24
references: 10627837
references: Chem Pharm Bull (Tokyo). 1999 Feb;47(2):220-5
references: 10071855
references: J Pharm Sci. 1999 Oct;88(10):1058-66
references: 10514356
references: Biotechnol Bioeng. 1998 Nov 5;60(3):301-9
references: 10099432
references: AAPS PharmSciTech. 2004 Oct 08;5(4):e61
references: 15760058
references: Int J Pharm. 2001 Oct 23;229(1-2):193-203
references: 11604272
references: Chem Pharm Bull (Tokyo). 1990 Mar;38(3):733-9
references: 2347016